Clinical trial
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation…
NCT00407043 · Ophthalmic Consultants of Long Island, Other · Completed
Key facts
| NCT number | NCT00407043 |
|---|---|
| Title | Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis |
| Official title | A Prospective, Multicenter, Randomized Controlled Study of the Effect of Lotepredol Etabonate on The Initiation of Dry Eye Treatment With Topical Cyclosporine |
| Lead sponsor | Ophthalmic Consultants of Long Island, Other |
| Collaborators | Bausch & Lomb Incorporated Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dry Eye Disease, Keratoconjunctivitis Sicca |
| Intervention type | Drug |
| Interventions | Lotemax, Restasis |
| Enrollment | 5 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Jul 21, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: